GeekWire

FEBRUARY 1, 2021

Adaptive Biotechnologies). Adaptive Biotechnologies has promoted one exec, while another is departing next month. Adaptive Biotechnologies’ EVP of Operations and Management Nancy Hill will depart the company in March. Bevier joined the F5 board in 2006. Mark Adams. Mark Adams is now COO.

Biotechnology 115

Biotechnology Fractional CTO CTO Hire Financial 115

GeekWire

OCTOBER 10, 2023

Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. The company said it is increasing focus on its ex vivo cell therapy product candidates, resulting in a “strategic re-positioning” and delaying other projects.

Biotechnology 100

Biotechnology .Net Report Company 100

GeekWire

MARCH 8, 2022

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, the company’s chief scientific officer. Adaptive Biotechnologies Photo). Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned. “We

Biotechnology 109

Biotechnology .Net Programming Company 109

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Sana CEO and president Steve Harr. Sana Photo). Sana signed an agreement with Beam Therapeutics for non-exclusive commercial rights to the Cambridge, Mass.-based based biotech’s gene editing system, called CRISPR-Cas12b.

Biotechnology 133

Biotechnology System Programming Engineering 133

GeekWire

FEBRUARY 3, 2021

Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of diseases through gene therapy and cell engineering — is generating buzz on Wall Street. That would net the biotechnology company $517 million if it sold at the midpoint of that range. Sana’s technology (screen grab via IPO filing).

Biotechnology 95

Biotechnology .Net Company Engineering 95

GeekWire

NOVEMBER 30, 2022

Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. Adaptive Biotechnologies , Absci , and Zymeworks also announced layoffs this year. Sana CEO Steve Harr. Sana Photo). Seattle startup TwinStrand Biosciences also reportedly laid off staff.

Biotechnology 105

Biotechnology Company Programming Financial 105

GeekWire

FEBRUARY 15, 2022

Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. GeekWire Photo / Charlotte Schubert). million in revenue last year, a 57% year-over-year increase.

Biotechnology 98

Biotechnology .Net Development Study 98

GeekWire

MARCH 9, 2022

Adaptive Biotechnologies has a new CFO. Tycho Peterson, Adaptive’s new CFO. Morgan Chase Photo). Tycho Peterson comes from J.P. Morgan Chase, where he most recently served in its healthcare group as managing director, life science tools and diagnostics.

Biotechnology 98

Biotechnology Healthcare Open Source Sports 98

GeekWire

AUGUST 12, 2024

A biotech prize for turning chemicals into food On the biotechnology front, the Mars Society plans to offer an incentive prize for methods that use microbes to convert simple chemicals, such as methane or methanol, into food. “Ask it anything you want, and you get the answer in multiple personalities,” he said.

Biotechnology 126

Biotechnology Chemicals Artificial Intelligence Engineering 126

GeekWire

SEPTEMBER 21, 2021

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. GeekWire Photos / Charlotte Schubert).

Biotechnology 98

Biotechnology Real Estate Analysis Research 98

GeekWire

JULY 27, 2020

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). Stephen Brashear/AP Images for Adaptive Biotechnologies).

Biotechnology 125

Biotechnology Real Estate Industry Microsoft 125

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 108

Biotechnology Education Web Services Insurance 108

GeekWire

AUGUST 23, 2021

In the previous four years, Adaptive Biotechnologies was the only Washington state biotech company to go public. Sana Biotechnology, for instance, is led by Steve Harr , former CFO and corporate development head at Juno Therapeutics, a Seattle company that went public in 2014 and was later acquired by Celgene for $9 billion.

Biotechnology 127

Biotechnology Company Trends .Net 127

GeekWire

JULY 2, 2020

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. The researchers said they have selected the two most promising DNA sequences for further testing. Researchers at OncoSenX are using Fusogenix for cancer research on the treatment of solid tumors.

Research 145

Research Pharmaceuticals Biotechnology Development 145

GeekWire

JULY 8, 2021

Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.

Biotechnology 132

Biotechnology Industry Real Estate Company 132

TechSpot

JULY 24, 2024

The UK Space Agency and BiologIC Technologies are partnering to develop advanced biotechnologies, including vaccines and gene therapies, for space manufacturing.

Biotechnology 111

Biotechnology Research Development 111

GeekWire

MAY 11, 2020

OncoSenX is a spinout out of Oisin Biotechnologies, a 5-year-old Seattle company also led by Scholz, a veteran biotech entrepreneur. The Seattle-based company just extended its oversubscribed SAFE (Simple Agreement for Future Equity) to allow for more capital, confirmed CEO Matthew Scholz. million to date.

Biotechnology 142

Biotechnology System Company 142

GeekWire

JULY 29, 2021

The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Leslie Alexandre, CEO of Life Sciences Washington. Biotech IPOs reached an all-time high last year, according to Biopharma Dive , and the pace is continuing into 2021.

Biotechnology 139

Biotechnology Company Pharmaceuticals Research 139

GeekWire

NOVEMBER 19, 2020

Others include Sana Biotechnology, Chinook Therapeutics, Kineta, Alpine Immune Sciences, Adaptive Biotechnologies, and more, in addition to work being done at Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Benaroya Research Institute, and others.

Biotechnology 145

Biotechnology Research CTO Development 145

GeekWire

NOVEMBER 13, 2020

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests. Adaptive Biotechnologies Photo).

Biotechnology 137

Biotechnology Study Comparison .Net 137

GeekWire

SEPTEMBER 26, 2024

Nautilus Biotechnology Photo) — After more than two decades at scientific instruments company Agilent Technologies, Ken Suzuki is now chief marketing officer for Nautilus Biotechnology. ” Ken Suzuki. Seattle-based Nautilus has designed a platform for analyzing proteomes, a term for the proteins produced by an organism.

CTO 108

CTO Healthcare Biotechnology Nonprofit 108

GeekWire

DECEMBER 30, 2020

In June, Seattle biotechnology upstart Sana Biotechnology revealed that it had raised more than $700 million in venture funding. Which of these Washington state companies did NOT go public in 2020: Accolade, Adaptive Biotechnologies, Athira Pharma, Silverback Therapeutics? Adaptive Biotechnologies (It went public in 2019).

Biotechnology 133

Biotechnology Sports Microsoft Research 133

GeekWire

JUNE 30, 2021

The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Three Washington state companies — Sana Biotechnology , Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year.

Company 132

Company Biotechnology .Net Programming 132

GeekWire

AUGUST 10, 2020

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 115

Biotechnology Industry Research .Net 115

GeekWire

FEBRUARY 26, 2021

This was a first-of-its kind diagnostic tool from Seattle-based Adaptive Biotechnologies , a company that develops technology to sequence the human immune system for the diagnosis and treatment of disease. Adaptive Biotechnologies’ new test, called T-Detect COVID , was developed in partnership with Microsoft.

Biotechnology 140

Biotechnology System Study Development 140

GeekWire

JANUARY 14, 2022

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. government has been buying to fight Omicron.

Biotechnology 106

Biotechnology Government Research Development 106

GeekWire

FEBRUARY 11, 2021

Spinout success: Other Fred Hutch spinouts include Juno Therapeutics and Adaptive Biotechnologies, while University of Washington research led to the launch of Icosavax, Neoleukin Therapeutics, Universal Cells, Cyrus Biotechnology and others.

Biotechnology 137

Biotechnology Research Healthcare Engineering 137

GeekWire

DECEMBER 9, 2024

Other spinouts associated with the institute include Cyrus Biotechnology , Sana Biotechnology , A-Alpha Bio and Xaira Therapeutics. AstraZeneca paid $1.1 billion to acquire a different spinout, Icosavax , which develops synthetic vaccines that target naturally occurring viruses.

Biotechnology 112

Biotechnology Pharmaceuticals Chemicals Research 112

GeekWire

MAY 12, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. GeekWire File Photo). The Seattle-based company posted a net loss of $31.4

Biotechnology 112

Biotechnology Pharmaceuticals .Net Microsoft 112

GeekWire

JUNE 10, 2021

This week Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. Remitly, ranked No. 3 on the GeekWire 200 list of top Pacific Northwest tech startups, has around 1,000 employees across its Seattle HQ and six other offices in Spokane, Wash.,

Company 143

Company Biotechnology Banking Mobile 143

GeekWire

JULY 7, 2021

Pacific Northwest biotechs that have gone public this year include Sana Biotechnology, which raised $587 million in its February IPO and Impel NeuroPharma, which raised $80 million through its IPO in April.

Development 142

Development Biotechnology Pharmaceuticals .Net 142

GeekWire

APRIL 16, 2021

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Adaptive Biotechnologies. So it’s little wonder that there’s stiff competition for the 2021 GeekWire Health Innovation of the Year.

Biotechnology 120

Biotechnology Virtualization Healthcare Artificial Intelligence 120

GeekWire

JUNE 4, 2020

The company, previously known as M3 Biotechnology, is committed to growing in Seattle as part of the local biotech and life sciences ecosystem , Kawas said. . “It really validates what we have done,” said Litton, a veteran biotech exec who previously co-founded Alder Biopharmaceuticals. The Michael J.

Development 145

Development Biotechnology Research Healthcare 145

GeekWire

SEPTEMBER 2, 2021

From top left, clockwise: inistro CEO Daphne Koller; Nautilus Biotechnology CEO Sujal Patel; Truveta CEO Terry Myerson; and Viome CEO Naveen Jain. Now he’s CEO of Nautilus Biotechnology, a Seattle startup using software to analyze proteins. Sujal Patel , CEO of Nautilus Biotechnology. billion in 2010. Nautilus Photo).

Software 144

Software Software Biotechnology Groups 144

GeekWire

MARCH 2, 2021

A few weeks ago, a longtime GeekWire reader sent a note expressing shock that Sana Biotechnology co-founder and CEO Steve Harr only owned 4.9% Given that the Seattle biotechnology company was on the cusp of a blockbuster stock market debut and now is valued at more than $6 billion, I responded that 4.9% ownership prior to the IPO.

Biotechnology 134

Biotechnology Company Examples Financial 134

GeekWire

AUGUST 11, 2021

So how do Washington state’s technology and biotechnology companies measure up? However, Adaptive Biotechnologies went public only two years ago, and it appears the rule does not apply for the first four to five years after an IPO. RELATED: The push for corporate board diversity is growing. Seemingly better.

Biotechnology 102

Biotechnology Company Meeting Nonprofit 102

GeekWire

JUNE 17, 2021

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington State University.” Athira Pharma CEO Leen Kawas at the 2018 GeekWire Summit. GeekWire Photo / Kevin Lisota).

Biotechnology 117

Biotechnology Journal Research Study 117